Immatics
10 followers
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets.
Org chart
Collapse
Carsten Reinhardt
Managing Director and Chief Development Officer
Rainer Kramer
Managing Director & Chief Business Officer
Cedrik Britten
Chief Medical Officer
Edward Sturchio
General Counsel and Corporate Secretary
Steffen Walter
Chief Operating Officer
Toni Weinschenk
Chief Innovation Officer
Venkat Ramanan
Chief Financial Officer
Amie Krause
Chief People Officer
Board & advisors
Hans-Georg Rammensee
Chairman of Scientific Advisory Board
Cassian Yee
Scientific Advisory Board Member
Patrick Hwu
Scientific Advisory Board Member
Anne Kerber
Scientific Advisory Board Member
Gwendolyn Binder
Member Of The Board Of Advisors
Roland Kontermann
Scientific Advisory Board
Hidde Ploegh
Scientific Advisory Board
Peter Chambré
Chairman
Crystal Mackall
Co-Chair
Heather L. Mason
Vice Chair
Adam Stone
Director
Michael G. Atieh
Director
